Navigation Links
West to Host Investor Day

LIONVILLE, Pa., March 7 /PRNewswire-FirstCall/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that it will conduct a live webcast of its Investor Day event on Thursday, March 13, 2008 from 8:30am to approximately 11:30am EDT. The event will be held at the Grand Hyatt Hotel in New York, New York.

The following members of management will provide an in-depth look at the Company's global operations, business segments, supply chain management and investments in innovation. Speakers will include:
-- Don Morel, Chairman and CEO

-- Steve Ellers, President and COO

-- Mike Schaefers, Director of Marketing, Europe/Asia Pacific

-- John Paproski, Vice President, Innovation

-- Bernie Lahendro, Vice President and General Manager, Daikyo Crystal


A live audio webcast and a copy of the presentations will be available through the Investor link of the Company's website, A replay of the audio portion will be available for 14 days. To access the live webcast, visit the company's Web site at least 15 minutes prior to the scheduled start time to download any necessary audio or plug-in software.

About West Pharmaceutical Services, Inc.

West Pharmaceutical Services, Inc. is a global manufacturer of components and systems for injectable drug delivery, including stoppers and seals for vials, and closures and disposable components used in syringe, IV and blood collection systems. The Company also provides products with application to the personal care, food and beverage markets. Headquartered in Lionville, Pennsylvania, West Pharmaceutical Services supports its partners and customers from 50 locations throughout North America, South America, Europe, Mexico, Japan, Asia and Australia. For more information, visit West at

Contacts: Investors and Financial Media:

West Pharmaceutical Services, Inc. FD

Michael A. Anderson Evan Smith / Theresa Kelleher

Vice President and Treasurer (212) 850-5600

(610) 594-3345

SOURCE West Pharmaceutical Services, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. BD to Present at Investor Healthcare Conferences
2. Jazz Pharmaceuticals, Inc. Announces Webcast of March 13 Investor Meeting
3. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Susquehanna Healthcare Conference
4. Kendle to Present at the 29th Annual Raymond James Institutional Investors Conference
5. NuRx Pharmaceuticals Retains Russo Partners for Investor Relations, Corporate Communications Counsel
6. PAREXEL International to Present at Raymond James 29th Annual Institutional Investors Conference
7. Investor Alert from Cauley Bowman Carney & Williams, PLLC: Update on Proposed Acquisition of CollaGenex Pharmaceuticals, Inc. - CGPI
8. CuraGen to Present at the BIO CEO & Investor Conference
9. SemBioSys to present at the 10th Annual BIO CEO & Investor Conference
10. Santaris Pharma to Present at 10th Annual Biotechnology Industry Organisation CEO & Investor Conference - February 11th, 2008
11. Emisphere Technologies to Web Cast BIO CEO & Investor Conference Presentation February 12
Post Your Comments:
(Date:11/26/2015)... , November 26, 2015 ... --> Accutest Research Laboratories, a ... Research Organization (CRO), has formed a ... Center - Temple Health for joint ... ,     (Photo: ) , ...
(Date:11/25/2015)... 25, 2015 2 nouvelles études permettent ... les différences entre les souches bactériennes retrouvées dans la ... des êtres humains . Ces recherches  ouvrent une nouvelle ... prise en charge efficace de l,un des problèmes ... chats .    --> 2 nouvelles études ...
(Date:11/25/2015)... , Nov. 25, 2015 /PRNewswire/ - Aeterna Zentaris Inc. ... its business and prospects remain fundamentally strong and ... (zoptarelin doxorubicin) recently received DSMB recommendation to continue ... following review of the final interim efficacy and ... Primary Endpoint in men with heavily pretreated castration- ...
(Date:11/25/2015)... ... November 25, 2015 , ... Jessica Richman and Zachary Apte, ... their initial angel funding process. Now, they are paying it forward to other ... stage investments in the microbiome space. In this, they join other successful ...
Breaking Biology Technology:
(Date:11/16/2015)... 16, 2015  Synaptics Inc. (NASDAQ: SYNA ... today announced expansion of its TDDI product portfolio ... controller and display driver integration (TDDI) solutions designed ... new TDDI products add to the previously-announced ... (WQHD resolution), and TD4322 (FHD resolution) solutions. All ...
(Date:11/10/2015)... , Nov. 10, 2015  In ... on the basis of product, type, application, ... included in this report are consumables, services, ... report are safety biomarkers, efficacy biomarkers, and ... this report are diagnostics development, drug discovery ...
(Date:11/2/2015)... 2015  SRI International has been awarded a contract ... services to the National Cancer Institute (NCI) PREVENT Cancer ... expertise, modern testing and support facilities, and analytical instrumentation ... toxicology studies to evaluate potential cancer prevention drugs. ... Cancer Drug Development Program is an NCI-supported pipeline to ...
Breaking Biology News(10 mins):